# Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

> **NCT03433807** · — · NO_LONGER_AVAILABLE · sponsor: **Santhera Pharmaceuticals**

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Idebenone

## Key facts

- **NCT ID:** NCT03433807
- **Lead sponsor:** Santhera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433807, "Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03433807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*